Osteogenesis imperfecta or Ekman Lobstein disease has no known treatment. The goals of treatment are to control disease symptoms, maintain health, and improve quality of life.Childhood is when brittle bone disease first appears. Even the fetus in utero exhibits alterations in the most severe instances.
1. Since osteogenesis imperfecta cannot be cured, treatment focuses on symptom management and improving overall quality of life. The reduction of fractures as well as the promotion of general health and function are treatment objectives.
2. Primary care physicians, geneticists, rehabilitation experts, endocrinologists, neurologists, orthopedic specialists, and pulmonologists may be on the treatment team.
3. Surgical methods to treat deformities or fix fractures are among the available treatments. Sometimes bone density is improved by using drugs like bisphosphonates, which are licensed for treating osteoporosis. When necessary, mobility aids such as wheelchairs, crutches, and walkers may be employed.
4. Infants with the most severe osteogenesis imperfecta have a terrible prognosis; the majority of them may not survive more than a few weeks. People with milder versions of the illness who receive appropriate medical care have a far better outlook, and many may live healthy, ordinary lives.
Frequent fractures,Hearing problems
Skeletal deformity,Blue sclerae